For preclinically exposed individuals with the potential to develop obesity, reduced GLP-1 signaling could be associated with lack of these sensors, more greatly increasing this risk for weight gain. The gene discussed is GLP1R; the disease is obesity due to melanocortin 4 receptor deficiency.